Zepp Health (ZEPP) EBITDA Margin (2016 - 2025)
Historic EBITDA Margin for Zepp Health (ZEPP) over the last 10 years, with Q3 2025 value amounting to 1.17%.
- Zepp Health's EBITDA Margin rose 283600.0% to 1.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 14.7%, marking a year-over-year increase of 35900.0%. This contributed to the annual value of 25.88% for FY2024, which is 177200.0% down from last year.
- As of Q3 2025, Zepp Health's EBITDA Margin stood at 1.17%, which was up 283600.0% from 10.27% recorded in Q2 2025.
- Over the past 5 years, Zepp Health's EBITDA Margin peaked at 3.9% during Q2 2021, and registered a low of 47.68% during Q1 2025.
- Its 5-year average for EBITDA Margin is 12.59%, with a median of 9.98% in 2022.
- Per our database at Business Quant, Zepp Health's EBITDA Margin plummeted by -311800bps in 2024 and then skyrocketed by 283600bps in 2025.
- Over the past 5 years, Zepp Health's EBITDA Margin (Quarter) stood at 0.61% in 2021, then tumbled by -1193bps to 6.62% in 2022, then soared by 111bps to 0.75% in 2023, then plummeted by -2090bps to 15.01% in 2024, then soared by 92bps to 1.17% in 2025.
- Its last three reported values are 1.17% in Q3 2025, 10.27% for Q2 2025, and 47.68% during Q1 2025.